Product Information
CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0842 per EA under NDC 59651086601. Its NADAC has been published 60 times since May 7, 2025.
Strength
250 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651086601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077859On Market Since
2/9/2024
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 60 times since May 7, 2025, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0842 per EA |
|---|---|
| All-time high | $0.0917 (Sep 10, 2025) |
| All-time low | $0.0842 (Jun 17, 2026) |
| 52-week high | $0.0917 |
| 52-week low | $0.0842 |
| Median price | $0.0896 |
| Average price | $0.0895 |
| Largest weekly change | -4.7% (Jun 17, 2026) |
| Weeks tracked | 60 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.0842 per EA (NDC 59651086601), effective Jun 24, 2026.
How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 8.0%. It has been tracked across 60 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?
Since May 7, 2025, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0842 (Jun 17, 2026) to a high of $0.0917 (Sep 10, 2025), with a median of $0.0896 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CIPROFLOXACIN HCL 250 MG TAB, but none are currently priced below it.
Who manufactures CIPROFLOXACIN HCL 250 MG TAB?
CIPROFLOXACIN HCL 250 MG TAB (NDC 59651086601) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification